This function is exclusive for Premium subscribers
Its recent $109m Series B infusion boosts the Indonesian startup's confidence for sustainability and regional expansion despite the current Covid-19 slowdown
Indonesian VCs on how they are doing deals during Covid-19, and their advice to startups, from how to cut costs to M&A
Nothing Found. You may try to search Kopi Kenangan instead.